Amsden GW |
Pharmacological considerations in the emergence of resistance. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10204634
|
Retsema JA |
Susceptibility and resistance emergence studies with macrolides. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10204635
|
Scaglione F et al. |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. |
1999 |
Br J Clin Pharmacol |
pmid:10215750
|
Khan AA et al. |
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10221415
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Ouadrhiri Y et al. |
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223943
|
Könönen E et al. |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223950
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Akova M et al. |
In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223958
|
Gorenek L et al. |
The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea. |
1999 Jan-Feb |
Hepatogastroenterology |
pmid:10228818
|
Taylor H |
Towards the global elimination of trachoma. |
1999 |
Nat. Med. |
pmid:10229224
|
Lietman T et al. |
Global elimination of trachoma: how frequently should we administer mass chemotherapy? |
1999 |
Nat. Med. |
pmid:10229236
|
Nowicki M et al. |
Partial regression of advanced cyclosporin-induced gingival hyperplasia after treatment with azithromycin. A case report. |
1998 |
Ann. Transplant. |
pmid:10234432
|
Carbon C and Poole MD |
The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. |
1999 |
J Chemother |
pmid:10326741
|
Cazzola M et al. |
Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. |
1999 |
J Chemother |
pmid:10326742
|
Petitta A et al. |
Economic evaluation of three methods of treating urogenital chlamydial infections in the emergency department. |
1999 |
Pharmacotherapy |
pmid:10331829
|
Cammarota G et al. |
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10333196
|
Wirnsberger GH and Pfragner R |
Comment on "Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients" by Nash and Zaltzman. |
1999 |
Transplantation |
pmid:10342326
|
Girgis NI et al. |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348767
|
Wolf K and Malinverni R |
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348778
|